Johnson & Johnson (NYSE:JNJ) Releases FY 2023 Earnings Guidance

Johnson & Johnson (NYSE:JNJ – Get Free Report) issued an update on its FY 2023 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of $10.00-$10.10 for the period, compared to the consensus estimate of $10.75. The company issued revenue guidance of $83.20 billion-$84.00 billion, compared to the consensus revenue estimate […]

Related Keywords

Kathryne Wengel ,Johnson ,William Hait ,Securities Exchange Commission ,Consumer Health ,Norges Bank ,Johnson Company Profile ,Moneta Group Investment Advisors ,Citigroup ,Barclays ,Morgan Stanley ,Imprint Wealth ,Get Free Report ,Exchange Commission ,Group Investment Advisors ,Johnson Daily ,Nyse Jnj ,Jnj ,Medical ,47816010 ,Guidance ,Earnings ,Preannouncement ,